- Newish Technology applied for clinical trials for NWRD09, a new #HPV therapeutic vaccine against HPV16-related tumors.
- @cansinobio_inc reported its recombinant shingles vaccine has completed all on-site work for Phase I trials conducted in Canada and now analysing data.
1
134
➡️@cansinobio_inc announced acceptance of New Drug Application for its DTCP Infant.
➡️The company also announced the launch of Phase I/II clinical trials for its recombinant polio vaccine in Indonesia, with the first subject enrolled in the Phase I trial.
uk.marketscreener.com/quote/…
1
1
115
➡️Guangzhou Patronus Biotech has obtained approval to conduct clinical trials in China for its recombinant RSV vaccine, LYB005, which previously began Phase I trials in Australia in July.
➡️TheraVac launched Phase I trials of its recombinant #shingles vaccine (CHO cell).
1
81
➡️The Beijing Institute of Biological Products of @ChinaSinopharm received IND approval from China’s CDE for its #Mpox vaccine.
➡️@WantaiBio announced the successful completion of Phase I clinical trials for its hepatitis E vaccine in the US.
1
107
➡️1,000 doses of bivalent #HPV vaccine Cecolin were donated to Nepal as part of the “HPV Vaccine and Cervical Cancer Screening Technology Demonstration Project” funded by China’s Ministry of Science and Technology.
1
70















